Clinical Trials on Rhinitis, Allergic

Total 2956 results

Northwestern University

Completed

Reduction of IgE Antibody in Human Allergic Subjects

Seasonal Allergic Rhinitis

United States
Glenmark Pharmaceuticals Ltd. India

Completed

Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301- PoC)

Seasonal Allergic Rhinitis

Canada
Shionogi

Completed

Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

Seasonal Allergic Rhinitis
AstraZeneca

Completed

Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia

Seasonal Allergic Rhinitis

Russian Federation
GlaxoSmithKline

Completed

Post Marketing Surveillance for Contac Bien Z in Japan

Allergic Rhinitis | Seasonal Allergic Rhinitis

Japan
Sunovion

Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Merck Sharp & Dohme LLC

Completed

A Study in Subjects With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis
Abbott

Completed

Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinitis

Russian Federation
Amneal Pharmaceuticals, LLC
Novum Pharmaceutical Research Services

Completed

Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber

Seasonal Allergic Rhinitis

Canada
Teva Pharmaceuticals USA

Unknown

Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

Perennial Allergic Rhinitis

United States
Sunovion

Completed

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Assessment of Fluticasone Propionate on Ocular Allergy Symptoms

Allergic Rhinitis | Seasonal Allergic Rhinitis

United States
University of Chicago
Schering-Plough

Terminated

Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Fraunhofer-Institute of Toxicology and Experimental...

Completed

Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC)

Seasonal Allergic Rhinitis
University of Chicago
Schering-Plough

Completed

Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?

Seasonal Allergic Rhinitis

United States
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen

Seasonal Allergic Rhinitis

Spain, Hungary
University of Chicago
GlaxoSmithKline

Completed

Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms

Seasonal Allergic Rhinitis

United States
University of Chicago
GlaxoSmithKline

Completed

Intranasal Steroids and the Nasal Ocular Response

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Sunovion

Completed

A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Perennial Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
AstraZeneca

Completed

Rhinocort Aqua Versus Placebo and Fluticasone Propionate

Seasonal Allergic Rhinitis
Sanofi

Completed

Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit

Seasonal Allergic Rhinitis

United States
University of Aarhus
Aarhus University Hospital

Completed

Eosinophil Markers and Development of Disease in Allergic Rhinitis

Seasonal Allergic Rhinitis
Alcon Research

Completed

Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial

Seasonal Allergic Rhinitis

United States
Alcon Research

Completed

Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
AstraZeneca

Completed

Children, Perennial Allergic Rhinitis (PAR), l-t Growth

Perennial Allergic Rhinitis
Pfizer

Completed

Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers

Seasonal Allergic Rhinitis

United Kingdom
University of Mississippi Medical Center
Kyowa Hakko Kogyo Co., Ltd.

Completed

Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Allergy Therapeutics

Completed

Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels

Respiratory Tract Infections | Allergy | Rhinitis, Allergic | Allergic Conjunctivitis | Allergic Asthma

Germany
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 in Subjects With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

China
Anhui Palo Alto Pharmaceuticals, Inc.

Recruiting

Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis

Allergic Rhinitis

China
Organon and Co

Completed

Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)

Allergic Rhinitis
Organon and Co

Completed

A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)

Perennial Allergic Rhinitis
Organon and Co

Completed

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)

Seasonal Allergic Rhinitis
Organon and Co
Quintiles, Inc.

Completed

Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)

Seasonal Allergic Rhinitis
Beijing Tongren Hospital

Completed

A Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis (MERAK)

Allergic Rhinitis

China
Novartis Pharmaceuticals

Completed

Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies

Allergic Rhinitis

Japan
Sandoz

Completed

Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.

Seasonal Allergic Rhinitis

Russian Federation
Sandoz

Completed

Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Bulgaria, Germany, Poland, Moldova, Republic of
Teva Pharmaceuticals USA

Terminated

Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients

Seasonal Allergic Rhinitis

United States
University of South Florida

Active, not recruiting

Effects of Pine Cone Extract on Serum IgE Levels in Perennial Rhinitis (PCE)

Perennial Allergic Rhinitis

United States
MEDA Pharma GmbH & Co. KG

Completed

MP-AzeFlu Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
Organon and Co

Completed

Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)

Seasonal Allergic Rhinitis

3

Subscribe